H2-Q4 (histocompatibility 2, Q region locus 4) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)
Gene: H2-Q4 (histocompatibility 2, Q region locus 4) Mus musculus
Analyze
No known orthologs.
Symbol: H2-Q4
Name: histocompatibility 2, Q region locus 4
RGD ID: 1610420
MGI Page MGI
Description: Predicted to enable several functions, including TAP complex binding activity; beta-2-microglobulin binding activity; and signaling receptor binding activity. Predicted to be involved in several processes, including antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; antigen processing and presentation of endogenous peptide antigen via MHC class Ib; and positive regulation of T cell mediated cytotoxicity. Predicted to be located in several cellular components, including Golgi medial cisterna; cell surface; and endoplasmic reticulum exit site. Predicted to be part of MHC class I peptide loading complex; MHC class I protein complex; and MHC class Ib protein complex. Predicted to be active in external side of plasma membrane and extracellular space. Is expressed in several structures, including brain; genitourinary system; hemolymphoid system gland; liver; and small intestine. Human ortholog(s) of this gene implicated in several diseases, including artery disease (multiple); asthma (multiple); autoimmune disease (multiple); eye disease (multiple); and inner ear disease (multiple). Orthologous to several human genes including HLA-B (major histocompatibility complex, class I, B); HLA-C (major histocompatibility complex, class I, C); and HLA-E (major histocompatibility complex, class I, E).
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: H-2Q4; H2-D1; H2-Gs1; H2-Gs10; MGC6571; MHC class I like protein GS10; MHC class II antigen D; Qa; Qa-; Qa-4; Qa4; Qat-; Qat-4; Qb-1; Qb1
RGD Orthologs
Alliance Orthologs
More Info homologs ...
Latest Assembly: GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391735,598,593 - 35,603,650 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1735,598,593 - 35,604,266 (+)EnsemblGRCm39 Ensembl
GRCm381735,379,617 - 35,384,674 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1735,379,617 - 35,385,290 (+)EnsemblGRCm38mm10GRCm38
MGSCv371735,516,562 - 35,521,619NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361735,516,564 - 35,521,594 (+)NCBIMGSCv36mm8
Cytogenetic Map17B1NCBI
cM Map1718.65NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
Gene Ontology Annotations     Click to see Annotation Detail View

References

References - curated
# Reference Title Reference Citation
1. Human leukocyte antigen (HLA)-B, DRB1, and DQB1 allotypes associated with disease and protection of trachoma endemic villagers. Abbas M, etal., Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1734-8. doi: 10.1167/iovs.08-2053. Epub 2008 Sep 29.
2. AIDS-associated Reiter's syndrome. Altman EM, etal., Ann Allergy. 1994 Apr;72(4):307-16.
3. HLA class I polymorphisms in Tunisian patients with otosclerosis. Bel Hadj Ali I, etal., Ann Hum Biol. 2012 May;39(3):190-4. doi: 10.3109/03014460.2012.671849. Epub 2012 Apr 4.
4. Profiling of human leukocyte antigens in Eales' disease. Biswas J, etal., Int Ophthalmol. 1997-1998;21(5):277-81.
5. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma. Blom DJ, etal., Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1865-72.
6. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Brown MA, etal., Ann Rheum Dis. 1996 Apr;55(4):268-70.
7. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Cheung YK, etal., Epilepsia. 2013 Jul;54(7):1307-14. doi: 10.1111/epi.12217. Epub 2013 May 20.
8. HLA-B phenotype modifies the course of Behcet's disease in Moroccan patients. Choukri F, etal., Tissue Antigens. 2003 Jan;61(1):92-6.
9. Association of the HLA-DR15/HLA-DQ6 haplotype with development of choroidal neovascular lesions in presumed ocular histoplasmosis syndrome. Dabil H, etal., Hum Immunol. 2003 Oct;64(10):960-4.
10. [Characteristics of the distribution of major histocompatibility system antigens in retinal vasculitis in patients with Behcet's disease]. Ermakova NA Vestn Oftalmol. 2003 Jan-Feb;119(1):31-3.
11. The role of the human leukocyte antigen system in retinopathy of prematurity: a pilot study. Flor-de-Lima F, etal., Acta Paediatr. 2013 Aug 29. doi: 10.1111/apa.12410.
12. Lack of association of HLA-B*51 with a severe disease course in Behcet's disease. Gul A, etal., Rheumatology (Oxford). 2001 Jun;40(6):668-72.
13. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Hammer RE, etal., Cell. 1990 Nov 30;63(5):1099-112.
14. An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4. Holland GN, etal., Am J Ophthalmol. 1989 Oct 15;108(4):370-4.
15. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people. Huang SM, etal., Tissue Antigens. 2003 Feb;61(2):154-8.
16. Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients. Hughes EH, etal., Tissue Antigens. 2005 Sep;66(3):195-9.
17. Genetic and non-genetic factors affecting the visual outcome of ocular Behcet's disease. Kang EH, etal., Hum Immunol. 2013 Oct;74(10):1363-7. doi: 10.1016/j.humimm.2013.06.036. Epub 2013 Jul 2.
18. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Kaniwa N, etal., Pharmacogenomics. 2008 Nov;9(11):1617-22. doi: 10.2217/14622416.9.11.1617.
19. Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behcet's disease. Kaya TI, etal., Clin Exp Dermatol. 2002 Sep;27(6):498-501.
20. Evaluation of HLA-A, -B, -Cw, and -DRB1 alleles frequency in Turkish patients with nasal polyposis. Keles B, etal., Otolaryngol Head Neck Surg. 2008 Oct;139(4):580-5. doi: 10.1016/j.otohns.2008.07.002.
21. Frequency of HLA antigens in Graves' hyperthyroidism and mitral valve prolapse. Kontopoulos A, etal., J Heart Valve Dis. 1996 Sep;5(5):543-7.
22. Audio-vestibular disturbances in Behcet's patients: report of 62 cases. Kulahli I, etal., Hear Res. 2005 May;203(1-2):28-31.
23. Association between HLA-B*46 allele and Graves disease in Asian populations: a meta-analysis. Li Y, etal., Int J Med Sci. 2013;10(2):164-70. doi: 10.7150/ijms.5158. Epub 2013 Jan 3.
24. [Association of HLA antigens with thyrotoxic periodic paralysis]. Liu WH, etal., Zhonghua Nei Ke Za Zhi. 1991 Jul;30(7):395-8, 454.
25. Human leukocyte antigen in childhood unilateral deafness. Matsuki K, etal., Arch Otolaryngol Head Neck Surg. 1989 Jan;115(1):46-7.
26. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection. Murphy B, etal., Transplantation. 1997 Jul 15;64(1):14-9.
27. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
28. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Orchard TR, etal., Gastroenterology. 2000 Feb;118(2):274-8.
29. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Orchard TR, etal., Gastroenterology. 2002 Sep;123(3):714-8.
30. HLA-B27-associated acute anterior uveitis in the University Referral Centre in North Thailand: clinical presentation and visual prognosis. Pathanapitoon K, etal., Br J Ophthalmol. 2006 Dec;90(12):1448-50. Epub 2006 Aug 9.
31. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. Price P, etal., J Clin Virol. 2001 Oct;22(3):279-87.
32. HLA typing in birdshot chorioretinopathy. Priem HA, etal., Am J Ophthalmol. 1988 Feb 15;105(2):182-5.
33. [Susceptibility genes, HLA and diabetic retinopathy in the Algerian population]. Raache R, etal., J Fr Ophtalmol. 2013 Mar;36(3):247-54. doi: 10.1016/j.jfo.2012.01.008. Epub 2012 Sep 14.
34. MHC-extended haplotypes in families of patients with Graves' disease. Ratanachaiyavong S, etal., Hum Immunol. 1993 Feb;36(2):99-111.
35. [Features of clinical manifestations of the globe, adnexal and orbital sarcoidosis]. Razumova IIu, etal., Vestn Oftalmol. 2013 Mar-Apr;129(2):35-40.
36. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
37. HLA antigens in Asian Indian patients with Graves' disease. Tandon N, etal., Clin Endocrinol (Oxf). 1990 Jul;33(1):21-6.
38. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results. Thurau SR, etal., Immunol Lett. 1997 Jun 1;57(1-3):193-201.
39. HLA B27 as predisposition factor to suffer age related macular degeneration. Villegas Becerril E, etal., Cell Mol Immunol. 2009 Aug;6(4):303-7. doi: 10.1038/cmi.2009.40.
40. Gamma-delta T cells as orally induced suppressor cells in rats: in vitro characterization. Wildner G, etal., Ann N Y Acad Sci. 2004 Dec;1029:416-21.
41. Characterization of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats. Yanagisawa H, etal., Am J Pathol. 1995 Oct;147(4):955-64.
42. Influence of human leukocyte antigen in the pathogenesis of Meniere's disease in the South Korean population. Yeo SW, etal., Acta Otolaryngol. 2002 Dec;122(8):851-6.
Additional References at PubMed
PMID:312902   PMID:1686840   PMID:1794054   PMID:2439640   PMID:2581893   PMID:2584927   PMID:2639903   PMID:2983348   PMID:2991930   PMID:3034582   PMID:3335397   PMID:3443307  
PMID:3701254   PMID:4044021   PMID:6088985   PMID:6280871   PMID:6304710   PMID:6399516   PMID:6966299   PMID:8732475   PMID:8833240   PMID:10349636   PMID:11042159   PMID:11076861  
PMID:11217851   PMID:12466851   PMID:12477932   PMID:16141072   PMID:16141073   PMID:18416856   PMID:18541714   PMID:21873635  


Genomics

miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:287
Count of miRNA genes:240
Interacting mature miRNAs:254
Transcripts:ENSMUST00000081435, ENSMUST00000173975
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCm39)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
10045977Tir9_mtrypanosome infection response 9 (mouse)Not determined172787811943885114Mouse
26884379Skwq5_mskull length QTL 5, 5 week (mouse)173311897454107028Mouse
1300885Mbis4_mMycobacterium bovis-induced systemic lupus erythematosus 4 (mouse)Not determined173517581770165926Mouse
1300890Bhr3_mbronchial hyperresponsiveness 3 (mouse)Not determined17397489048866091Mouse
11075105Modc1_mmodifier of Odc1 (mouse)172771579245622654Mouse
1300995Fembrs4_mfemur breaking strength 4 (mouse)Not determined171506165249061760Mouse
15039348Nmrs37_mNAFLD-associated magnetic resonance shift 37 (mouse)172781520961815209Mouse
4141357Mrdq1_mmodifier of retinal degeneration QTL 1 (mouse)Not determined3098790348039703Mouse
1302152Skull25_mskull morphology 25 (mouse)Not determined171681972150819843Mouse
1302028Asbb3_mautoimmune susceptibility in C57BL/6J and BALB/c 3 (mouse)Not determined171087811944878219Mouse
15039354Nmrs36_mNAFLD-associated magnetic resonance shift 36 (mouse)171914502553145025Mouse
4141215Mnic1_mmacronutrient intake, carbohydrate 1 (mouse)Not determined485475245670266Mouse
1300787Cd8mts5_mCD8 memory T cell subset 5 (mouse)Not determined17858491442585149Mouse
13524847Asrq8a_macoustic startle response 8a (mouse)171264696146646961Mouse
1300914Pcir4_mperiosteal circumference 4 (mouse)Not determined171506165249061760Mouse
13452396Leusq3_mleucocytosis susceptibility QTL 3 (mouse)171746220851462345Mouse
13452399Leusq6_mleucocytosis susceptibility QTL 6 (mouse)171746220851462345Mouse
1300535Char3_mP. chabaudi malaria resistance QTL 3 (mouse)Not determined171746220851462345Mouse
4140955Plgr1_mplague resistance locus 1 (mouse)Not determined3103350065033630Mouse
1302070Tbbmd7_mtotal body bone mineral density 7 (mouse)Not determined171506165249061760Mouse
10412214Sxbq3_mSGC/Knj cross B6 QTL 3 (mouse)Not determined171746220851462345Mouse
10412083Sm2_msusceptibility to Schistosoma mansoni infection 2 (mouse)Not determined171702994351030078Mouse
10412204Bbaa29_mB.burgdorferi-associated arthritis 29 (mouse)Not determined172605118560051352Mouse
10043949Pbft7_mpercent body fat 7 (mouse)Not determined17689393640893936Mouse
4141067Hbnr2_mHeligmosomoides bakeri nematode resistance 2 (mouse)Not determined1188597145886119Mouse
12904946Tammq8_mtibialis anterior muscle mass QTL 8 (mouse)171245178746451787Mouse
10412198Sst5_msusceptibility to tuberculosis 5 (mouse)Not determined172507658355712970Mouse
4142342Lfnq4_mlung function QTL 4 (mouse)Not determined1120648439364059Mouse
10412196Bbaa28_mB.burgdorferi-associated arthritis 28 (mouse)Not determined172558491443976235Mouse
1301935Skull24_mskull morphology 24 (mouse)Not determined17858491442585149Mouse
1302189Dps3_mdelta power in slow-wave sleep 3 (mouse)Not determined173381972136250180Mouse
1301331Lbw1_mlupus NZB x NZW 1 (mouse)Not determined171841835752420983Mouse
1301840Ssial4_msusceptibility to sialadenitiss 4 (mouse)Not determined171817541252178214Mouse
1300692Blmpf1_mbleomycin-induced pulmonary fibrosis 1 (mouse)Not determined173206165237644775Mouse
1357789Kdnw3_mkidney weight 3 (mouse)Not determined17485475247885665Mouse
1301338Lmr1_mleishmaniasis resistance 1 (mouse)Not determined171008134086996400Mouse
1300703Uvbi2_mUVB induced immunosuppression 2 (mouse)Not determined172862240662622654Mouse
1301056Pas2_mpulmonary adenoma susceptibility 2 (mouse)Not determined171842214152424327Mouse
1301454Eae5_msusceptibility to experimental allergic encephalomyelitis 5 (mouse)Not determined172461275058612864Mouse
14747010Mancz14_mmandible centroid size 14 (mouse)171199818445998184Mouse
1302005Loco2_mlocomotor activity 2 (mouse)Not determined172688497260885114Mouse
4141272Tfv1_mtotal food volume 1 (mouse)Not determined485475265637357Mouse
1300602Eye2_meye weight 2 (mouse)Not determined172650533741105037Mouse
10412276Leci2_mleukocyte endothelial cell interactions 2 (mouse)Not determined17334817537348299Mouse
1302140Wta4_mweight adult 4 (mouse)Not determined171681972150819843Mouse
1300706Alan1_malloantigen response 1 (mouse)Not determined17485475246469702Mouse
1558886Lgth9_mbody length 9 (mouse)Not determined171506165249061760Mouse
1558758Kcal2_mkilocalorie 2 (mouse)Not determined172640101252911704Mouse
4142150Stheal11_msoft tissue heal 11 (mouse)Not determined171228621183361768Mouse
11081168Tir7_mtrypanosome infection response 7 (mouse)171412337248123496Mouse
1300589Myaa2_mmodifier of Yaa 2 (mouse)Not determined173013255564132666Mouse

Markers in Region
H2-Q4  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm381735,381,182 - 35,381,397UniSTSGRCm38
MGSCv371735,518,127 - 35,518,342UniSTSGRCm37
Cytogenetic Map17B1UniSTS
cM Map1719.16UniSTS
H2-Q4  
Mouse AssemblyChrPosition (strand)SourceJBrowse
Cytogenetic Map17B1UniSTS


Sequence


Ensembl Acc Id: ENSMUST00000081435   ⟹   ENSMUSP00000080159
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl1735,598,593 - 35,603,650 (+)Ensembl
GRCm38.p6 Ensembl1735,379,617 - 35,384,674 (+)Ensembl
Ensembl Acc Id: ENSMUST00000173975
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl1735,598,593 - 35,604,266 (+)Ensembl
GRCm38.p6 Ensembl1735,379,617 - 35,385,290 (+)Ensembl
RefSeq Acc Id: NM_001143689   ⟹   NP_001137161
RefSeq Status: VALIDATED
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm391735,598,593 - 35,603,650 (+)NCBI
GRCm381735,379,617 - 35,384,674 (+)NCBI
MGSCv371735,516,562 - 35,521,619 (+)ENTREZGENE
cM Map17 ENTREZGENE
Sequence:
RefSeq Acc Id: NP_001137161   ⟸   NM_001143689
- Peptide Label: precursor
- UniProtKB: Q95H92 (UniProtKB/TrEMBL),   Q8HWB2 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSMUSP00000080159   ⟸   ENSMUST00000081435
Protein Domains
Ig-like   MHC class I-like antigen recognition-like

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q8HWB2-F1-model_v2 AlphaFold Q8HWB2 1-354 view protein structure

Promoters
RGD ID:13675866
Promoter ID:EPDNEW_M22083
Type:multiple initiation site
Name:H2-Q4_1
Description:Mus musculus histocompatibility 2, Q region locus 4 (H2-Q4),mRNA.
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_M22084  
Experiment Methods:Single-end sequencing.
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm381735,379,617 - 35,379,677EPDNEW
RGD ID:13675874
Promoter ID:EPDNEW_M22084
Type:initiation region
Name:H2-Q4_2
Description:Mus musculus histocompatibility 2, Q region locus 4 (H2-Q4),mRNA.
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_M22083  
Experiment Methods:Single-end sequencing.
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm381735,380,413 - 35,380,473EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene MGI:95933 AgrOrtholog
Ensembl Genes ENSMUSG00000035929 Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Transcript ENSMUST00000081435 ENTREZGENE
  ENSMUST00000081435.5 UniProtKB/TrEMBL
Gene3D-CATH 2.60.40.10 UniProtKB/TrEMBL
  3.30.500.10 UniProtKB/TrEMBL
InterPro Ig-like_dom UniProtKB/TrEMBL
  Ig-like_dom_sf UniProtKB/TrEMBL
  Ig-like_fold UniProtKB/TrEMBL
  Ig/MHC_CS UniProtKB/TrEMBL
  Ig_C1-set UniProtKB/TrEMBL
  MHC_class-I_related UniProtKB/TrEMBL
  MHC_I-like_Ag-recog UniProtKB/TrEMBL
  MHC_I-like_Ag-recog_sf UniProtKB/TrEMBL
  MHC_I/II-like_Ag-recog UniProtKB/TrEMBL
  MHC_I_a_a1/a2 UniProtKB/TrEMBL
KEGG Report mmu:15015 UniProtKB/TrEMBL
MGD MGI:95933 ENTREZGENE
NCBI Gene 15015 ENTREZGENE
PANTHER CLASS IB MHC ANTIGEN QA-2-RELATED UniProtKB/TrEMBL
  MHC CLASS I-RELATED UniProtKB/TrEMBL
Pfam C1-set UniProtKB/TrEMBL
  MHC_I UniProtKB/TrEMBL
PhenoGen H2-Q4 PhenoGen
PRINTS MHCCLASSI UniProtKB/TrEMBL
PROSITE IG_LIKE UniProtKB/TrEMBL
  IG_MHC UniProtKB/TrEMBL
SMART IGc1 UniProtKB/TrEMBL
Superfamily-SCOP MHC_I/II-like_Ag-recog UniProtKB/TrEMBL
  SSF48726 UniProtKB/TrEMBL
UniProt Q0WXH7_MOUSE UniProtKB/TrEMBL
  Q0WXI6_MOUSE UniProtKB/TrEMBL
  Q3UWA5_MOUSE UniProtKB/TrEMBL
  Q8HWB2 ENTREZGENE, UniProtKB/TrEMBL
  Q95H92 ENTREZGENE, UniProtKB/TrEMBL


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-04-05 H2-Q4  histocompatibility 2, Q region locus 4  H2-Gs10  MHC class I like protein GS10  Data merged from RGD:2302691 737654 PROVISIONAL
2016-02-17 H2-Gs10  MHC class I like protein GS10  H2-gs10    Symbol and/or name change 5135510 APPROVED